Jubilant Life Sciences arm gets US FDA nod for coronary drug

New Delhi: Jubilant Life Sciences today said its wholly-owned subsidiary has received approval from the US health regulator for RUBY-FILL -- Rubidium 82 generator and elution system -- used in diagnosis of coronary artery disease in the US market.

Representational image. Getty images

Representational image. Getty images

In a BSE filing, the company said, "Its wholly-owned subsidiary Jubilant Pharma, through one of its units Jubilant DraxImage Montreal Canada, has received US Food and Drug Administration approval for RUBY-FILL, for its New Drug

Application (NDA) pursuant to section 505 (b)(2) filing." It further said: "The product is expected to be launched in the current quarter (third quarter of the financial year 2017) under the company's registered brand name RUBY-FILL for which the current estimated US market size is USD 76 million and has a potential to grow up to USD 250 million annually in the next five years."

Jubilant Life Sciences Chairman Shyam S Bhartia and Co Chairman and MD Hari S Bhartia said the medical community was looking forward to this approval, which is expected to give further boost to revenues and profitability of the company along with "the robust existing product base".

Jubilant Life Sciences said this approved new drug application provides for the use of RUBY-FILL for Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease.

Shares of Jubilant Life Sciences were trading 6.82 percent higher at Rs 656.55 on BSE.


Updated Date: Oct 03, 2016 12:02 PM

Also Watch

Watch: Firstpost test rides the new Thunderbird 500X in Goa and walks you through the Royal Enfield Garage Cafe
  • Tuesday, April 17, 2018 Varun Dhawan on Shoojit Sircar's October, 5-star reviews and working with Anushka Sharma in Sui Dhaaga
  • Saturday, April 14, 2018 Ambedkar Jayanti: Re-visiting Babasaheb's ideals exposes fake Dalit politics of Rahul Gandhi and Congress
  • Monday, April 9, 2018 48 hours with Huawei P20 Pro: Triple camera offering is set to redefine smartphone imaging
  • Monday, April 16, 2018 Rajyavardhan Singh Rathore interview: Sports can't be anyone's fiefdom, we need an ecosystem to nurture raw talent

Also See